CREDIT SUISSE AG/ - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$269,899
-54.6%
85,142
-28.8%
0.00%
-100.0%
Q2 2023$593,990
+13.6%
119,515
+12.9%
0.00%0.0%
Q1 2023$522,850
-18.8%
105,840
+3.3%
0.00%0.0%
Q4 2022$644,253
-27.5%
102,425
+24.4%
0.00%0.0%
Q3 2022$889,000
-4.3%
82,317
+1.1%
0.00%0.0%
Q2 2022$929,000
+51.1%
81,391
+20.6%
0.00%0.0%
Q1 2022$615,000
-36.3%
67,493
+4.4%
0.00%0.0%
Q4 2021$965,000
-51.9%
64,668
-17.2%
0.00%0.0%
Q3 2021$2,006,000
+4.0%
78,067
+5.5%
0.00%0.0%
Q2 2021$1,929,000
-12.3%
73,972
+18.8%
0.00%0.0%
Q1 2021$2,199,000
-34.1%
62,289
-52.9%
0.00%
-50.0%
Q4 2020$3,336,000
-24.0%
132,164
+13.6%
0.00%
-33.3%
Q3 2020$4,388,000
-15.7%
116,367
-4.3%
0.00%
-25.0%
Q2 2020$5,207,000
+263.1%
121,612
+64.8%
0.00%
+300.0%
Q1 2020$1,434,000
-57.5%
73,806
-43.1%
0.00%
-50.0%
Q4 2019$3,371,000
+542.1%
129,742
+572.9%
0.00%
Q3 2019$525,000
+40.4%
19,280
+38.1%
0.00%
Q2 2019$374,00013,9610.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$26,829,00010.04%
Wildcat Capital Management, LLC 1,716,370$25,608,0004.17%
TPG GP A, LLC 18,716,306$279,247,0002.79%
Casdin Capital, LLC 2,650,000$39,538,0001.11%
Lombard Odier Asset Management (Switzerland) SA 996,116$14,862,0000.95%
Coastal Bridge Advisors, LLC 301,929$4,505,0000.94%
HARBOR CAPITAL ADVISORS, INC. 119,547$1,784,0000.65%
Pier Capital, LLC 294,968$4,401,0000.46%
Navalign, LLC 64,428$961,0000.38%
Gratus Capital, LLC 191,871$2,863,0000.26%
View complete list of ALLOGENE THERAPEUTICS INC shareholders